Internationally recognized pharmaceutical company. Specialist distribution of medicines and equipment for medical supplies. Production of high-quality nutritional supplements. Very large growth potential.

The group was established in the 90 s with the registered office in China and is now developing into a leading pharmaceutical company in Asia with vertically integrated intermediates and formulations based on R & D manufacture and sales. As an innovative and dynamic group in pharmaceuticals the products mainly involve in Psychotropic Cardiovascular Antithrombotic Antitumor Gastrointestinal Anti-infection(antivirotic) and Veterinary. The Company s market covers Asia Europe Africa South Am

Family owned business with more than 100 years, strong track record and expansion plans in progress. The shareholders are considering divesting its stake in the company sincethere isa successionlack. The laboratory employs over 330 employees and more than 30 sales representatives working throughout the Brazilian territory. Although the company produces only medicine, It is authorized to manufacture medicines, cosmetics, perfumes and toiletries. There are 31 medication records at ANVISA, among